Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Magro

Showing results (211-220 of 340) with videos related to

Pageof 34
Sort By:
Journal of Clinical Medicine|February 11, 2023
iSTART-II: An Update on the i Support Therapy-Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative ColitisFerdinando D'Amico, Fernando Magro, Benedicte Caron, et al.
Journal of Crohn'S & Colitis|September 24, 2011
Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel diseaseLaurent Peyrin-Biroulet, Marc Ferrante, Fernando Magro, et al.
Advances in Therapy|March 14, 2022
Correction to: Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 EraStefan Schreiber, Shomron Ben-Horin, Rieke Alten, et al.
Journal of Crohn'S & Colitis|October 9, 2012
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosisAxel Dignass, Rami Eliakim, Fernando Magro, et al.
Inflammatory Bowel Diseases|August 7, 2023
Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert ConsensusFerdinando D'Amico, Fernando Magro, Britta Siegmund, et al.
United European Gastroenterology Journal|May 4, 2023
Ustekinumab improves health-related quality of life in patients with moderate-to-severe Crohn's disease: Results up to Week 104 of the STARDUST trialJulian Panés, Séverine Vermeire, Geert R D'Haens, et al.
Journal of Crohn'S & Colitis|June 1, 2013
Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III)Fernando Magro, Laurent Peyrin-Biroulet, Harry Sokol, et al.
Plos One|January 5, 2017
Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel DiseaseCristiana Costa Pereira, Cecília Durães, Rosa Coelho, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 26, 2025
Circulating Metabolite Signatures Linking Physical Activity to Inflammatory Bowel Disease Risk and Interactions With Genetic SusceptibilityZixuan He, Yuhao Sun, Hanyi Huang, et al.
Journal of Crohn'S & Colitis|December 18, 2014
European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseasesAxel U Dignass, Christoph Gasche, Dominik Bettenworth, et al.
Pageof 34

Showing results (211-220 of 340) with videos related to

Sort By:
Pageof 34
Journal of Clinical Medicine|February 11, 2023
iSTART-II: An Update on the i Support Therapy-Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative ColitisFerdinando D'Amico, Fernando Magro, Benedicte Caron, et al.
Journal of Crohn'S & Colitis|September 24, 2011
Results from the 2nd Scientific Workshop of the ECCO. I: Impact of mucosal healing on the course of inflammatory bowel diseaseLaurent Peyrin-Biroulet, Marc Ferrante, Fernando Magro, et al.
Advances in Therapy|March 14, 2022
Correction to: Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 EraStefan Schreiber, Shomron Ben-Horin, Rieke Alten, et al.
Journal of Crohn'S & Colitis|October 9, 2012
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosisAxel Dignass, Rami Eliakim, Fernando Magro, et al.
Inflammatory Bowel Diseases|August 7, 2023
Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert ConsensusFerdinando D'Amico, Fernando Magro, Britta Siegmund, et al.
United European Gastroenterology Journal|May 4, 2023
Ustekinumab improves health-related quality of life in patients with moderate-to-severe Crohn's disease: Results up to Week 104 of the STARDUST trialJulian Panés, Séverine Vermeire, Geert R D'Haens, et al.
Journal of Crohn'S & Colitis|June 1, 2013
Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III)Fernando Magro, Laurent Peyrin-Biroulet, Harry Sokol, et al.
Plos One|January 5, 2017
Association between Polymorphisms in Antioxidant Genes and Inflammatory Bowel DiseaseCristiana Costa Pereira, Cecília Durães, Rosa Coelho, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 26, 2025
Circulating Metabolite Signatures Linking Physical Activity to Inflammatory Bowel Disease Risk and Interactions With Genetic SusceptibilityZixuan He, Yuhao Sun, Hanyi Huang, et al.
Journal of Crohn'S & Colitis|December 18, 2014
European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseasesAxel U Dignass, Christoph Gasche, Dominik Bettenworth, et al.
Pageof 34